Histide ^Company

Histide is a biotech company that has developed a new class of therapeutic agents called Cell Recoding Molecules (CRMs). These CRMs stimulate the cell's natural abilities to redirect its own fate by integrating accurate extracellular signals. Histide's approach, called Recoding Therapeutics, goes beyond traditional cell, gene or RNA based therapies. The company has a technological breakthrough with a wide range of potential uses in pharmaceuticals, medical devices, and medical cosmetics. Their mission is to establish CRMs as a new class of therapeutic solutions, and their vision is to unlock the potential of Recoding Therapeutics by establishing an ecosystem of teams and partners to provide enhanced therapeutic solutions for diseases that are currently untreatable or undruggable.